# Oncospace, Inc. — Form D/A

Oncospace, Inc. of BALTIMORE, MD, a company, filed a Form D amendment with the SEC on 2019-05-15. The offering totals $1.5M, of which $900K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-05-15
- Form: D/A
- Accession: 0001773640-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $900K
- Remaining: $600K
- Investors: 11
- Date of first sale: 2019-03-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-337126

## Issuer

- Name: Oncospace, Inc.
- CIK: 0001773640
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2018
- Address: 1812 ASHLAND AVENUE SUITE 100, BALTIMORE, MD, 21205
- Phone: 608-239-6871

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Todd McNutt | Director | Baltimore, MD |
| Daniel Roche | Director | Baltimore, MD |
| Praveen Sinha | Director | Baltimore, MD |
| Todd McNutt | Executive Officer | Baltimore, MD |
| Praveen Sinha | Executive Officer | Baltimore, MD |
| Daniel Roche | Related Person | Baltimore, MD |
| Praveen Sinha | Related Person | Baltimore, MD |
| Todd McNutt | Related Person | Baltimore, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-04-11](https://search.stillhousedata.com/formd/0001773640-19-000001) | D | $1.5M | $675K |

## More

- [CIK 1773640 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1773640&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001773640-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.